Skip to content
DataLookout
Menu

BDDONCT07915986

Brain Dopamine Dynamics in Obesity

StatusNot Yet Recruiting
PhasePhase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Dopamine (DA) release
Timeframe: Visit 4, approximately week 4. Baseline D2/3R binding potential will be assessed at T=30'. PET time-activity curves are then measured continuously for 60 minutes from milkshake onset.
Time to onset of DA peaks
Timeframe: Visit 4, approximately week 4. PET time-activity curves are measured continuously for 60 minutes from milkshake onset (30-90 minutes after initiation of radiotracer administration).
Duration of DA peaks
Timeframe: Visit 4, approximately week 4.PET time-activity curves are measured continuously for 60 minutes from milkshake onset (30-90 minutes after initiation of radiotracer administration).
Time to onset of DA peaks between men and women
Timeframe: Visit 4, approximately week 4. PET time-activity curves are measured continuously for 60 minutes from milkshake onset (30-90 minutes after initiation of radiotracer administration).
Duration of DA peaks between men and women
Timeframe: Visit 4, approximately week 4. PET time-activity curves are measured continuously for 60 minutes from milkshake onset (30-90 minutes after initiation of radiotracer administration).
Magnitude of DA release between men and women
Timeframe: Visit 4, approximately week 4. PET time-activity curves are measured continuously for 60 minutes from milkshake onset (30-90 minutes after initiation of radiotracer administration).

Secondary (11)

Glucose
Insulin
FFA
Gut peptides (tbd)
Yale Food Addiction Scale 2.0 score
Show 6 moreShow less
Barratt Impulsiveness Scale (BIS-11) score
Dietary Fat and Free Sugar - Short Questionnaire (DFS)
Change in Delay Discounting Task
Change in Iowa Gambling Task score
Behavioral Inhibition System/Behavioral Activation System Scale score
Change in Visual Analogue Scale (VAS) score

Arms and interventions

Adults with obesityExperimental

Four visits per participant: screening, PET practice session, MRI+behavioral assessment, milkshake+PET scan.

Adults with normal weightExperimental

Four visits per participant: screening, PET practice session, MRI+behavioral assessment, milkshake+PET scan.

Other: Milkshake

Devices: NeuroEXPLORER

Drugs: [11C]raclopride

Sites

1 site in 1 country

  • Yale School of MedicineNew Haven, Connecticut, United States